1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. United States >
  6. California >
  7. Viracta Therapeutics >
  8. M&A

Viracta Therapeutics Mergers & Acquisitions

Viracta Therapeutics M&A Summary

Viracta Therapeutics has acquired 3 companies, including 3 in the last 5 years. A total of 3 acquisitions came from private equity firms.

Viracta Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 3

Viracta Therapeutics

Viracta Therapeutics, Inc.

2533 South Coast Highway 101 Suite 210,
Cardiff, California 92007
United States,
(858) 400-8470
www.viracta.com

All (1) Buy (1) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2020-11-30 Sunesis · Life Science
South San Francisco, California · www.sunesis.com

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics for oncology and other serious diseases. Sunesis was founded in 1998 and is based in South San Francisco, California.

Advisors: Cooley , MTS Health Partners 		- Merger

Viracta Therapeutics
Advisors: Evercore Group , Wilson Sonsini Goodrich & Rosati

Alta Partners PE

Bay City Capital PE

Nexus Life Science Partners PE


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal